Strontium ranelate: a new paradigm in the treatment of osteoporosis

Bibliography

• LEHNERDT F: Zur frage der substitution des calcium im knochensystem durch. Beitz. Path. Anat. Allg. Path. (1910) 47:215–245.
   Google Scholar
• CANALIS E, HOTT M, DELOFFRE P, TSOUDEROS Y, MARIE PJ: The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone (1996) 18(6):517–523.
   PubMed Web of Science ®Google Scholar
• MARIE PJ, AMMANN P, BOIVIN G, REY C: Mechanisms of action and therapeutic potential of strontium in bone. Cakil Tissue mt. (2001) 69:121–129.
   PubMed Web of Science ®Google Scholar
• IZUMISAWA T, MOROHASHI T, AMANO H, YAMADA S: The effect of stable strontium on calcium metabolism : II. Effect of la-hydroxyvitamin D3 in strontium-fed rats and inhibitory effect of strontium on bone resorption in vitro. J. Bone Miner. Metab. (1994) 12:43–49.
   Google Scholar
• TAKAHASHI N, SASAKI T, TSOUDEROS Y, SUDA T: S12911-2 inhibits osteoclastic bone resorption in vitro J. Bone Miner. Res. (2003) 18(6):1082–1087.
   PubMed Web of Science ®Google Scholar
• BARON R, TSOUDEROS Y: In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eat Pbannacol. (2002) 450:11–17.
   Web of Science ®Google Scholar
• BUEHLER J, CHAPPUIS P, SAFFAR JL, TSOUDEROS Y, VIGNERY A: Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone (2001) 29:176–179.
   PubMed Web of Science ®Google Scholar
• BOIVIN G, DELOFFRE P, PERRAT B et al: Strontium distribution and interactions with bone mineral density in monkey iliac bone after strontium salt (S12911) administration. Bone Miner. Res. (1996) 11(9):1302–1311.
   PubMed Web of Science ®Google Scholar
• MOROHASHI T, SANO T, HARM K, YAMADA S: Effects of strontium on calcium metabolism in rats II. Strontium prevents the increased rate of bone turnover in ovariectomized rats. fpn .1. Pbannacol. (1995) 68:153-159. Expert Op/n. Investig. Drugs (2004) 13(7)863
   Google Scholar
• MARIE PJ, HOTT M, MODROWSKI D et al.: An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintining bone formation in estrogen-deficient rats. Bone Muter. Res. (1993) 8:607–615.
   PubMed Web of Science ®Google Scholar
• •A study showing that for the first time an agent is able to concomitantly decrease bone resorption and stimulate bone formation.
   Google Scholar
• HOTT M, DELOFFRE P, TSOUDEROS Y, MARIE PJ: S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone (2003) 33:115–123.
   PubMed Web of Science ®Google Scholar
• REGINSTER JY, DEROISY R, DOUGADOS M, JUPSIN I, COLETTE J, ROUX C: Prevention of early postmenopausal bone loss by strontium ranelate : a randomized, two-year, double-blind, dose-ranging, placebo-controlled trial. Osteoporos. Int (2002) 13:925–931.
   PubMed Web of Science ®Google Scholar
• MEUNIER PJ, SLOSMAN D, DELMAS P et al.: Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis: a 2-year randomized placebo controlled trial. J. Clin. Endocrinol Metabolism, (2002) 87:2060–2066.
   PubMed Web of Science ®Google Scholar
• BOIVIN G, FOOS E, TUPINON-MATHIEU I, MEUNIER PJ: Strontium deposition in bone is dose dependent and does not alter the degree of mineralization of bone in osteoporotic patients treated with strontium ranelate. J. Bone Mbar.]: Res. (2000) 15(S1):305.
   Google Scholar
• REGINSTER JY, DIEZ-PEREZ A, ORTOLANI S, PORS-NIELSEN S, MEUNIER PJ: Calcium-vitamin D supplementation in clinical trials of osteoporosis should be titrated on the basis of pre-study assessments. Osteoporos. Int. (2002) 13(S1):524.
   Google Scholar
• REGINSTER JY, SPECTOR T, BADURSKI J et al.: A short-term run-in study can significantly contribute to increasing the quality of long-term osteoporosis trials. The strontium ranelate Phase III program. Osteoporos. mt. (2002) 13 (51):S30
   Google Scholar
• GENANT HK, WU CY, VAN KUIJK C, NEWIT MC: Vertebral semi quantitative assessment using a semi-quantitative technique. J. Bone Miner. Res. (1993) 8:1137–1148.
   PubMed Web of Science ®Google Scholar
• MEUNIER PJ, ROUX C, ORTOLANI S, BADURSKI J et al: Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis. Osteoporos. Int. (2002) 13(S1):045.
   Google Scholar
• MEUNIER PJ, ROUX C, SEEMAN E et al.: The effect of strontium ranelate on the risk of vertebral fracture in Women with Post Menopausal Osteoporosis. N Engl. J. Med. (2004) 350:459–468.
   PubMed Web of Science ®Google Scholar
• ••The first approved demonstration of the antifracture efficacy of strontium ranelate in osteoporosis.
   Google Scholar